1. Home
  2. CPIX vs NTWK Comparison

CPIX vs NTWK Comparison

Compare CPIX & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • NTWK
  • Stock Information
  • Founded
  • CPIX 1999
  • NTWK 1997
  • Country
  • CPIX United States
  • NTWK United States
  • Employees
  • CPIX N/A
  • NTWK N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • CPIX Health Care
  • NTWK Technology
  • Exchange
  • CPIX Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • CPIX 51.5M
  • NTWK 56.1M
  • IPO Year
  • CPIX 2009
  • NTWK 1998
  • Fundamental
  • Price
  • CPIX $3.55
  • NTWK $4.56
  • Analyst Decision
  • CPIX
  • NTWK
  • Analyst Count
  • CPIX 0
  • NTWK 0
  • Target Price
  • CPIX N/A
  • NTWK N/A
  • AVG Volume (30 Days)
  • CPIX 29.6K
  • NTWK 116.0K
  • Earning Date
  • CPIX 11-06-2025
  • NTWK 11-12-2025
  • Dividend Yield
  • CPIX N/A
  • NTWK N/A
  • EPS Growth
  • CPIX N/A
  • NTWK 316.67
  • EPS
  • CPIX N/A
  • NTWK 0.25
  • Revenue
  • CPIX $42,071,813.00
  • NTWK $66,088,229.00
  • Revenue This Year
  • CPIX N/A
  • NTWK N/A
  • Revenue Next Year
  • CPIX N/A
  • NTWK N/A
  • P/E Ratio
  • CPIX N/A
  • NTWK $18.00
  • Revenue Growth
  • CPIX 11.34
  • NTWK 7.65
  • 52 Week Low
  • CPIX $1.04
  • NTWK $2.14
  • 52 Week High
  • CPIX $7.25
  • NTWK $5.75
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 58.22
  • NTWK 49.31
  • Support Level
  • CPIX $3.29
  • NTWK $4.45
  • Resistance Level
  • CPIX $3.69
  • NTWK $4.63
  • Average True Range (ATR)
  • CPIX 0.22
  • NTWK 0.24
  • MACD
  • CPIX 0.03
  • NTWK -0.04
  • Stochastic Oscillator
  • CPIX 77.25
  • NTWK 27.27

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

Share on Social Networks: